10.07.2015 Views

Hlavičkový papier interný - SVK - Meduni-Wien Aktuell

Hlavičkový papier interný - SVK - Meduni-Wien Aktuell

Hlavičkový papier interný - SVK - Meduni-Wien Aktuell

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

525. NsP Žilina, Bytčica, Psychiatrické oddelenie, 010 09 Žilina, MUDr.DagmarŠtrocholcová............................................................................127Phase IIa Efficacy and safety trial of capadenoson in patients with chronic stable anginaKód štúdie: 68-4986/12484, 2007-000425-22Žiadateľ: Bayer, spol. s.r.o.Obchodná 2811 06 BratislavaSKCentrá:1. FNsP Bratislava, Mickiewiczova 13, II. Interná klinika, 813 69Bratislava, MUDr. Ľudovít Gašpar2. NsP Nové Zámky, Slovenská 11/A, Klinika vnútorného lekárstva, 940 34NovéZámky, MUDr. Tibor Ďuriš3. Kardiocentrum Nitra s.r.o., Fraňa Mojtu 35, 949 01 Nitra, MUDr. MariánHranai4. Cardioconsult, s.r.o., Čajkovského 5, 811 04 Bratislava, MUDr. KatarínaMalíková............................................................................128A randomised, double-blind, placebo- and olanzapine-controlled, parallel-group study to evaluate the efficacy and safety of 3 fixed doses of S 33138 in treatment of patients with an acute episodeof Schizophrenia. A phase IIb, international, multicentre, 8-week studyKód štúdie: CL2-33138-011, 2006-006184-23Žiadateľ: Servier s.r.o.Klimentská 46110 02 Praha 1ČRCentrá:1. FNsP Univerzity P.J. Šafárika, Trieda SNP 1, I. Psychiatrická klinika,040 11 Košice, MUDr. Eva Pálová, PhD.2. Psychiatrická nemocnica Michalovce, A. Hrehovčíka 1, 071 01 Michalovce,MUDr. Monika Biačková3. NsP Rimavská Sobota, Kraskova 1, Psychiatrické oddelenie, 979 12RimavskáSobota, MUDr. Peter Korcsog4. FNsP Bratislava, Ružinovská 6, Psychiatrická klinika SZU, 826 06Bratislava, MUDr. Lívia Vavrušová............................................................................129Efficacy and safety of 3 fixed doses of S33138 versus placebo andrisperidone in treatment of schizophrenic patients with predominant enduring negative symptoms. A phase IIb, international, multicentric, randomised, double-blind, placebo and risperidone controlled,paralel-group, 12-week studyKód štúdie: CL2-33138-018, 2007-003193-25Žiadateľ: Servier s.r.o.Klimentská 46110 02 Praha 1ČR

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!